Wikidata

(Q61864716)

English

A Study to Compare the Efficacy and Safety of Obinutuzumab + Venetoclax (GDC-0199) Versus Obinutuzumab + Chlorambucil in Participants With Chronic Lymphocytic Leukemia

clinical trial

In more languages

Statements

title
A Prospective, Open-Label, Multicenter Randomized Phase III Trial to Compare The Efficacy and Safety of A Combined Regimen of Obinutuzumab and Venetoclax (GDC-0199/ABT-199) Versus Obinutuzumab and Chlorambucil in Previously Untreated Patients With CLL and Coexisting Medical Conditions (English)
0 references
sponsor
Hoffmann-La Roche
0 references
country
Argentina
0 references
Australia
0 references
Austria
0 references
Brazil
0 references
Bulgaria
0 references
Canada
0 references
Croatia
0 references
Denmark
0 references
Estonia
0 references
France
0 references
Germany
0 references
Italy
0 references
Mexico
0 references
New Zealand
0 references
Poland
0 references
Romania
0 references
Spain
0 references
Switzerland
0 references
United Kingdom
0 references
start time
31 December 2014
0 references
end time
17 August 2018
0 references
number of participants
445
0 references
research intervention
venetoclax
0 references
obinutuzumab
0 references
chlorambucil
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61864716&oldid=2166519815"